| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.14B | 92.15B | 86.42B | 79.29B | 79.54B | 80.22B |
| Gross Profit | 20.13B | 20.29B | 18.80B | 17.61B | 15.29B | 14.81B |
| EBITDA | 11.89B | 11.45B | 10.37B | 9.81B | 7.52B | 5.57B |
| Net Income | 5.21B | 5.46B | 4.81B | 4.56B | 3.07B | 2.88B |
Balance Sheet | ||||||
| Total Assets | 191.71B | 179.86B | 164.40B | 147.50B | 127.91B | 136.03B |
| Cash, Cash Equivalents and Short-Term Investments | 23.18B | 30.55B | 31.62B | 31.25B | 32.60B | 30.76B |
| Total Debt | 123.80B | 107.54B | 91.61B | 86.79B | 73.74B | 84.78B |
| Total Liabilities | 146.49B | 131.97B | 117.54B | 104.84B | 88.95B | 99.66B |
| Stockholders Equity | 39.43B | 42.14B | 38.80B | 34.79B | 31.26B | 28.86B |
Cash Flow | ||||||
| Free Cash Flow | 9.43B | -14.20B | -2.11B | -8.12B | 17.22B | 7.25B |
| Operating Cash Flow | 9.63B | -13.30B | 460.00M | -7.55B | 19.32B | 10.53B |
| Investing Cash Flow | 48.00M | -636.00M | -2.39B | -160.00M | -4.17B | 3.85B |
| Financing Cash Flow | -5.08B | 12.53B | 2.40B | 5.91B | -9.90B | -21.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | ¥13.24B | 170.52 | ― | 3.44% | ― | ― | |
62 Neutral | ¥16.87B | 15.76 | ― | 3.75% | 19.17% | -42.56% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥118.83B | 13.82 | ― | 5.49% | -16.48% | -77.63% | |
54 Neutral | ¥49.77B | -118.04 | ― | 5.45% | 21.56% | 12.28% | |
52 Neutral | ¥12.01B | 13.48 | ― | 4.61% | -2.47% | 7.50% | |
51 Neutral | ¥7.90B | -14.29 | ― | 3.58% | 10.75% | 117.39% |